Decreased Antibody Response to Influenza Vaccination in Kidney Transplant Recipients: A Prospective Cohort Study

American Journal of Kidney Diseases

Volumn 54, Issue 1, 2009, Pages 112-121

  Birdwell, Kelly A ^a   Ikizler, Mine R ^a   Sannella, Edith C ^a   Wang, Li ^a   Byrne, Daniel W ^a   Ikizler, T Alp ^a   Wright, Peter F ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

immunosuppression; Influenza; kidney transplant; tacrolimus; vaccination

Indexed keywords

ANTIVIRUS AGENT; CREATININE; INACTIVATED VACCINE; INFLUENZA VACCINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITROGEN; PREDNISONE; TACROLIMUS; UREA; VIRUS ANTIBODY; VIRUS HEMAGGLUTININ;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG SAFETY; FEMALE; GRAFT RECIPIENT; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SINGLE DRUG DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HUMANS; IMMUNITY; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ORTHOMYXOVIRIDAE; PROSPECTIVE STUDIES; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 67449143239     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.09.023     Document Type: Article

References (33)

1. Kotton C.N., and Fishman J.A. Viral infection in the renal transplant recipient. J Am Soc Nephrol 16 (2005) 758-1774
2. Vilchez R.A., Fung J., and Kusne S. The pathogenesis and management of influenza virus infection in organ transplant recipients. Transpl Infect Dis 4 (2002) 177-182
3. Fiore A.E., Shay D.K., Haber P., et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 56 RR-6 (2007) 1-54
4. Carroll R.N., Marsh S.D., O'Donoghue E.P., Breeze D.C., and Shackman R. Response to influenza vaccine by renal transplant patients. Br Med J 2 (1974) 701-703
5. Pabico R.C., Douglas R.G., Betts R.F., McKenna B.A., and Freeman R.B. Antibody response to influenza vaccination in renal transplant patients: Correlation with allograft function. Ann Intern Med 85 (1976) 431-436
6. Stiver H.G., Graves P., Meiklejohn G., Schroter G., and Eickhoff T.C. Impaired serum antibody response to inactivated influenza A and B vaccine in renal transplant recipients. Infect Immun 16 (1977) 738-741
7. Kumar S.S., Ventura A.K., and VanderWerf B. Influenza vaccination in renal transplant recipients. JAMA 239 (1978) 840-842
8. Briggs W.A., Rozek R.J., Migdal S.D., et al. Influenza vaccination in kidney transplant recipients: Cellular and humoral immune responses. Ann Intern Med 92 (1980) 471-477
9. Huang K.L., Armstrong J.A., and Ho M. Antibody response after influenza immunization in renal transplant patients receiving cyclosporin A or azathioprine. Infect Immun 40 (1983) 421-424
10. Versluis D.J., Beyer W.E., Masurel N., Wenting G.J., and Weimar W. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 42 (1986) 376-379
11. Sanchez-Fructuoso A.I., Prats D., Naranjo P., et al. Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: Mycophenolate versus azathioprine. Transplantation 69 (2000) 436-439
12. Foley R.N., and Collins A.J. End-stage renal disease in the United States: An update from the United States Renal Data System. J Am Soc Nephrol 18 (2007) 2644-2648
13. Schwartz B., and Martin S.W. Principles and Practice of Pediatric Infectious Diseases. In: Long S.S. (Ed). Principles of epidemiology and public health. (ed 3) (2008), Elsevier, Philadelphia, PA
14. European Committee for Proprietary Medicinal Products. Note for Guidance on Harmonization of Requirements for Influenza Vaccines, March 1997 (CPMP/BWP/214/96) (1997), European Agency for the Evaluation of Medicinal Products, Brussels, Belgium
15. Fox J.P., Hall C.E., Cooney M.K., and Foy H.M. Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. Am J Epidemiol 116 (1982) 212-227
16. Warburton M.F. Immunization against influenza. Med J Aust 1 (1972) 546-547
17. Rudenko L.G., Slepushkin A.N., Monto A.S., et al. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis 168 (1993) 881-887
18. Levey A.S., Coresh J., Greene T., et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006) 247-254
19. Kendal A.P., Skehel J.J., and Pereira M.S. Concepts and Procedures for Laboratory-Based Influenza Surveillance (1982), US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta, GA
20. Peters D.H., Fitton A., Plosker G.L., and Faulds D. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. Drugs 46 (1993) 746-794
21. US Organ Procurement and Transplantation Network (OPTN) and the Scientific Registry of Transplant Recipients (SRTR). 2007 Annual Report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1997-2006 (2007), Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD
22. Hardinger K.L., Schnitzler M.A., Miller B., et al. Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation. Transplantation 78 (2004) 136-141
23. Kirk A.D. Induction immunosuppression. Transplantation 82 (2006) 593-602
24. Keshtkar-Jahromi M., Argani H., Rahnavardi M., et al. Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: A controlled trial. Am J Nephrol 28 (2008) 654-660
25. Scharpe J., Evenepoel P., Maes B., et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 8 (2008) 332-337
26. Englund J.A., Walter E.B., Fairchok M.P., Monto A.S., and Neuzil K.M. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Pediatrics 115 (2005) 1039-1047
27. Neuzil K.M., Jackson L.A., Nelson J., et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 194 (2006) 1032-1039
28. Edwards K.M., Dupont W.D., Westrich M.K., Plummer Jr. W.D., Palmer P.S., and Wright P.F. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 169 (1994) 68-76
29. Hoskins T.W., Davies J.R., Smith A.J., Allchin A., Miller C.L., and Pollock T.M. Influenza at Christ's Hospital: March, 1974. Lancet 1 (1976) 105-108
30. Keitel W.A., Cate T.R., Couch R.B., Huggins L.L., and Hess K.R. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 15 (1997) 1114-1122
31. Dinits-Pensy M., Forrest G.N., Cross A.S., and Hise M.K. The use of vaccines in adult patients with renal disease. Am J Kidney Dis 46 (2005) 997-1011
32. Osanloo E.O., Berlin B.S., Popli S., et al. Antibody responses to influenza vaccination in patients with chronic renal failure. Kidney Int 14 (1978) 614-618
33. Gilbertson D.T., Unruh M., McBean A.M., Kausz A.T., Snyder J.J., and Collins A.J. Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int 63 (2003) 738-743